"NAMPT" Related Products


Recombinant Human NAMPT, FLAG-tagged

Cat. No.: NAMPT-2168H
Product Overview: Recombinant Human Nicotinamide Nhosphoribosyltransferase is produced inHEK 293 cells.Full length Human Nampt (Visfatin/PBEF) (aa 1-491) is fused at the N-terminus to a FLAG-tag.
Description: Phosphoribosyltransferase (NAmPRTase or Nampt) also known as pre-B-cell colony-enhancing factor 1 (PBEF1) or visfatin is an enzyme that in humans is encoded by the PBEF1 gene. This protein has also been reported to be a cytokine (PBEF) that promotes B cell maturation and inhibits neutrophil apoptosis.
Source: HEK 293 cells.
Concentration: 0.5mg/ml.
Purity: ≥95% (SDS-PAGE).
Formulation: Liquid. 0.2µm-filtered solution in PBS.
Endotoxin Content: <0.1EU/µg protein (LAL test).
Storage And Stability: -20°C. For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.
Gene Name: NAMPT nicotinamide phosphoribosyltransferase [ Homo sapiens ]
Synonyms: NAMPT; nicotinamide phosphoribosyltransferase; NAmPRTase; pre-B cell-enhancing factor; pre-B-cell colony enhancing factor 1; pre-B-cell colony-enhancing factor 1; EC; VF; PBEF; PBEF1; VISFATIN; MGC117256; DKFZp666B131; 1110035O14Rik
Gene ID: 10135
mRNA Refseq: NM_005746
Protein Refseq: NP_005737
UniProt ID: Q80Z29
Chromosome Location: 7q22.3
Pathway: Nicotinate and nicotinamide metabolism; Metabolism of vitamins and cofactors
Function: cytokine activity; drug binding; nicotinamide phosphoribosyltransferase activity; protein homodimerization activity; transferase activity, transferring glycosyl groups

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.